Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Fabbri

Showing results (51-60 of 92) with videos related to

Pageof 10
Sort By:
Tumori|February 8, 2013
Phase II trial of non-pegylated liposomal doxorubicin and low-dose prednisone in second-line chemotherapy for hormone-refractory prostate cancerMarco Montanari, Francesco Fabbri, Ermanno Rondini, et al.
Current Oncology (Toronto, Ont.)|February 24, 2022
Appropriateness and Economic Analysis of Conventional Circulating Biomarkers Assessment in Early Breast Cancer: A Real-World Experience from the E.Pic.A StudyRoberta Maltoni, William Balzi, Tania Rossi, et al.
International Journal of Molecular Sciences|December 24, 2021
MicroRNA-16 Restores Sensitivity to Tyrosine Kinase Inhibitors and Outperforms MEK Inhibitors in <i>KRAS</i>-Mutated Non-Small Cell Lung CancerFrancesca Fanini, Erika Bandini, Meropi Plousiou, et al.
Nutrients|September 9, 2022
Extra Virgin Olive Oil (EVOO), a Mediterranean Diet Component, in the Management of Muscle Mass and Function PreservationSara Salucci, Anna Bartoletti-Stella, Alberto Bavelloni, et al.
Frontiers in Medicine|July 12, 2021
Case Report: Analysis of Circulating Tumor Cells in a Triple Negative Spindle-Cell Metaplastic Breast Cancer PatientTania Rossi, Michela Palleschi, Davide Angeli, et al.
Cancers|August 26, 2022
Dissecting Molecular Heterogeneity of Circulating Tumor Cells (CTCs) from Metastatic Breast Cancer Patients through Copy Number Aberration (CNA) and Single Nucleotide Variant (SNV) Single Cell AnalysisTania Rossi, Davide Angeli, Michela Tebaldi, et al.
Cancer Cell International|November 24, 2012
Inhibition of breast cancer cell proliferation in repeated and non-repeated treatment with zoledronic acidToni Ibrahim, Laura Mercatali, Emanuele Sacanna, et al.
Journal of Cellular Physiology|July 11, 2008
Mitotic catastrophe and apoptosis induced by docetaxel in hormone-refractory prostate cancer cellsFrancesco Fabbri, Dino Amadori, Silvia Carloni, et al.
Cancers|September 5, 2020
Single-Cell NGS-Based Analysis of Copy Number Alterations Reveals New Insights in Circulating Tumor Cells Persistence in Early-Stage Breast CancerTania Rossi, Giulia Gallerani, Davide Angeli, et al.
Cancer Letters|February 20, 2013
Detection and recovery of circulating colon cancer cells using a dielectrophoresis-based device: KRAS mutation status in pure CTCsFrancesco Fabbri, Silvia Carloni, Wainer Zoli, et al.
Pageof 10

Showing results (51-60 of 92) with videos related to

Sort By:
Pageof 10
Tumori|February 8, 2013
Phase II trial of non-pegylated liposomal doxorubicin and low-dose prednisone in second-line chemotherapy for hormone-refractory prostate cancerMarco Montanari, Francesco Fabbri, Ermanno Rondini, et al.
Current Oncology (Toronto, Ont.)|February 24, 2022
Appropriateness and Economic Analysis of Conventional Circulating Biomarkers Assessment in Early Breast Cancer: A Real-World Experience from the E.Pic.A StudyRoberta Maltoni, William Balzi, Tania Rossi, et al.
International Journal of Molecular Sciences|December 24, 2021
MicroRNA-16 Restores Sensitivity to Tyrosine Kinase Inhibitors and Outperforms MEK Inhibitors in <i>KRAS</i>-Mutated Non-Small Cell Lung CancerFrancesca Fanini, Erika Bandini, Meropi Plousiou, et al.
Nutrients|September 9, 2022
Extra Virgin Olive Oil (EVOO), a Mediterranean Diet Component, in the Management of Muscle Mass and Function PreservationSara Salucci, Anna Bartoletti-Stella, Alberto Bavelloni, et al.
Frontiers in Medicine|July 12, 2021
Case Report: Analysis of Circulating Tumor Cells in a Triple Negative Spindle-Cell Metaplastic Breast Cancer PatientTania Rossi, Michela Palleschi, Davide Angeli, et al.
Cancers|August 26, 2022
Dissecting Molecular Heterogeneity of Circulating Tumor Cells (CTCs) from Metastatic Breast Cancer Patients through Copy Number Aberration (CNA) and Single Nucleotide Variant (SNV) Single Cell AnalysisTania Rossi, Davide Angeli, Michela Tebaldi, et al.
Cancer Cell International|November 24, 2012
Inhibition of breast cancer cell proliferation in repeated and non-repeated treatment with zoledronic acidToni Ibrahim, Laura Mercatali, Emanuele Sacanna, et al.
Journal of Cellular Physiology|July 11, 2008
Mitotic catastrophe and apoptosis induced by docetaxel in hormone-refractory prostate cancer cellsFrancesco Fabbri, Dino Amadori, Silvia Carloni, et al.
Cancers|September 5, 2020
Single-Cell NGS-Based Analysis of Copy Number Alterations Reveals New Insights in Circulating Tumor Cells Persistence in Early-Stage Breast CancerTania Rossi, Giulia Gallerani, Davide Angeli, et al.
Cancer Letters|February 20, 2013
Detection and recovery of circulating colon cancer cells using a dielectrophoresis-based device: KRAS mutation status in pure CTCsFrancesco Fabbri, Silvia Carloni, Wainer Zoli, et al.
Pageof 10